Marina Santiago

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer et al. · Science Signaling · 2020 · 365 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Samuel D. Banister, Mitchell Longworth, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2016 · 247 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Absence of Entourage: Terpenoids Commonly Found in <i>Cannabis sativa</i> Do Not Modulate the Functional Activity of Δ ⁹ -THC at Human CB ₁ and CB ₂ Receptors

Marina Santiago, Shivani Sachdev, Jonathon C. Arnold et al. · Cannabis and Cannabinoid Research · 2019 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Cannabichromene is a cannabinoid CB ₂ receptor agonist

Michael Udoh, Marina Santiago, S.O. Devenish et al. · British Journal of Pharmacology · 2019 · 99 citations · Full text

Medicine, Pharmacology, Cell Signaling +10

A Continuous, Fluorescence-based Assay of µ-Opioid Receptor Activation in AtT-20 Cells

Alisa Knapman, Marina Santiago, Yan Ping Du et al. · SLAS DISCOVERY · 2012 · 69 citations · Full text

Medicine, Pharmacology, Cell Signaling +16